Transthyretin Amyloidosis With Polyneuropathy
1 clinical trials · Condition
◉ Watch Transthyretin Amyloidosis With Polyneuropathy
| Record | Firm | Date |
|---|---|---|
| Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations (NCT07654855) | AstraZeneca | 2026-09-01 |
Track Transthyretin Amyloidosis With Polyneuropathy automatically
Every clearance here is in the API, with alerts when new ones post.